Oxygenation improvement with almitrine bismesylate in the hepatopulmonary syndrome

Respiratory Medicine Extra

Volumn 2, Issue 3, 2006, Pages 81-84

  Milhe, François ^a   Reynaud Gaubert, Martine ^a   Magnan, Antoine ^a   Delpierre, Stéphane ^b   Vervloet, Daniel ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Laboratoire d'Explorations Fonctionnelles Respiratoires   (France)

Author keywords

Cirrhosis; Hepatopulmonary syndrome; Hypoxemia; Intrapulmonary vascular dilatations

Indexed keywords

ALMITRINE DIMESILATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INFUSION; DYSPNEA; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; LUNG ALVEOLUS OXYGEN TENSION; LUNG GAS EXCHANGE; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; RESPIRATORY ALKALOSIS; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33748983992     PISSN: 17449049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmedx.2006.03.004     Document Type: Article

References (17)

1. Rodriguez-Roisin R., Krowka M.J., Hervé P., and Fallon M.B. Highlights of ERS task force on pulmonary-hepatic vascular disorders. J Hepatol 42 (2005) 924-927
2. Lange P.A., and Stoller J.K. The hepatopulmonary syndrome. Ann Intern Med 122 (1995) 521-529
3. Hoeper M.M., Krowka M.J., and Strassburg P. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 363 (2004) 461-468
4. Battaglia S.E., Pretto J.J., Irwing L.B., et al. Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation. Hepatology 25 (1997) 1228-1232
5. Taille C., Cadranel J., Bellocq A., et al. Liver transplantation for hepatopulmonary syndrome: a ten experience in Paris, France. Transplantation 75 (2003) 1482-1489
6. Krowka M.J., and Cortese D.A. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 105 (1994) 1528-1537
7. Nunes H., Lebrec D., Mazmanian M., et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 164 (2001) 879-885
8. Luo B., Liu L., Tang L., et al. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 38 (2003) 556-563
9. Rolla G., Bucca C., and Brussino L. Methylene blue in the hepatopulmonary syndrome. N Eng J Med 331 (1994) 1098
10. Brussino L., Bucca C., Morello M., et al. Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-l-arginine methyl ester in hepatopulmonary syndrome. Lancet 362 (2003) 43-44
11. Abrams G.A., and Fallon M.B. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastroenterol 27 (1998) 232-235
12. Lockart A. Pharmacological properties of almitrine bismesylate. Eur Respir J Dis Suppl 126 (1983) 225-231
13. Roch A., Papazian L., Bregeon F., et al. High or low doses of almitrine bismesylate in ARDS patients responding to inhaled NO and receiving norepinephrine?. Intensive Care Med 27 (2001) 1737-1743
14. Krowka M.J., and Cortese D.A. Severe hypoxemia associated with liver disease:Mayo Clinic experience and the experimental use of almitrine bismesylate. Mayo Clinic Proc 62 (1987) 164-173
15. Nakos G., Evrenoglou D., Vassilakis N., et al. Haemodynamics and gas exchange in liver cirrhosis: the effect of orally administered almitrine bismesylate. Respir Med 87 (1993) 93-98
16. Bardsley P.A., Howard P., Tang O., et al. Sequential treatment with low dose of almitrine bismesylate in hypoxaemic chronic obstructive airways disease. Eur Respir J 5 (1992) 1054-1061
17. Howard P. Hypoxia, almitrine and peripheral neuropathy. Thorax 44 (1989) 247-250